Metabolic syndrome and serum fatty acid patterns in serum phospholipids in hypertriglyceridemic persons with human immunodeficiency virus
| Autor: | Pei-Ra Ling, Kristy Hendricks, Alice M. Tang, Heidi Sheehan, Charlotte Andersson, Margo N. Woods, Kimberly R Dong, Bruce R. Bistrian, Christine Wanke |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty Lipodystrophy Anti-HIV Agents AIDS and other wasting syndromes Medicine (miscellaneous) HIV Infections Biology chemistry.chemical_compound Insulin resistance Blood serum Internal medicine medicine Humans Phospholipids Triglycerides Hypertriglyceridemia Metabolic Syndrome chemistry.chemical_classification Nutrition and Dietetics Triglyceride Fatty Acids virus diseases Fatty acid Middle Aged medicine.disease Endocrinology chemistry Case-Control Studies Lipogenesis lipids (amino acids peptides and proteins) Female Arachidonic acid Metabolic syndrome |
| Zdroj: | The American Journal of Clinical Nutrition. 89:1180-1187 |
| ISSN: | 0002-9165 |
| DOI: | 10.3945/ajcn.2009.27444 |
| Popis: | Background: HIV infection and its treatment are associated with abnormal lipid profiles. High triglyceride concentrations and low HDL-cholesterol concentrations are the most common health abnormalities and raise concerns about an increased risk of cardiovascular disease. Objective: We compared the fatty acid patterns of serum phospholipids between persons with HIV and non-HIV controls to determine whether there are differences that explain the elevated triglyceride concentrations, insulin resistance, and inflammation that are part of the metabolic syndrome in patients with HIV. Design: Thirty-nine persons with HIV and elevated serum triglycerides (>150 mg/dL) and/or indicators of insulin resistance were recruited to examine fatty acid profiles in serum phospholipid fractions relative to those of 2 control groups without HIV (n = 31). Results: Higher concentrations of 16:1 and 18:0 fatty acids in the phospholipid fraction indicated increased lipogenesis in the HIV patients and in the non-HIV controls at risk of the metabolic syndrome. However, the subjects with HIV had higher concentrations of both n–6 (omega-6) and n–3 fatty acids of higher elongation and desaturation levels, which indicated a greater promotion of these pathways in this population. The nanomolar percentage (%nmol) arachidonic acid was the same in all 3 groups. Conclusions: Persons with and without HIV, at risk of the metabolic syndrome, show indications of increased lipogenesis, more so in subjects with HIV taking medication. Higher proportions of distal elongation and desaturation fatty acid products were seen only in the phospholipids fatty acid fraction of the subjects with HIV. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|